Safety and efficacy of inpatient pulmonary rehabilitation for patients hospitalised with an acute exacerbation of chronic obstructive pulmonary disease: a systematic review protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
23 06 2021
Historique:
entrez: 24 6 2021
pubmed: 25 6 2021
medline: 29 6 2021
Statut: epublish

Résumé

Pulmonary rehabilitation (PR) following an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) reduces the risk of hospital admissions, and improves physical function and health-related quality of life. However, the safety and efficacy of in-hospital PR during the most acute phase of an AECOPD is not well established. This paper describes the protocol for a systematic review with meta-analysis to determine the safety and efficacy of inpatient acute care PR during the hospitalisation phase. Medical literature databases and registries MEDLINE, EMBASE, Physiotherapy Evidence Database, Cumulative Index to Nursing and Allied Health Literature, Canadian Agency for Drugs and Technologies in Health, CENTRAL, Allied and Complementary Medicine Database, WHO trials portal and ClinicalTrials.gov will be searched for articles from inception to June 2021 using a prespecified search strategy. We will identify randomised controlled trials that have a comparison of in-hospital PR with usual care. PR programmes had to commence during the hospitalisation and include a minimum of two sessions. Title and abstract followed by full-text screening will be conducted independently by two reviewers. A meta-analysis will be performed if there is sufficient homogeneity across selected studies or groups of studies. The Population, Intervention, Comparator, Outcomes and Study characteristics framework will be used to standardise the data collection process. The quality of the cumulative evidence will be assessed using the Grading of Recommendations, Assessment, Development and Evaluations framework. AECOPD results in physical limitations which are amenable to PR. This review will assess the safety and efficacy of in-hospital PR for AECOPD. The results will be presented in a peer-reviewed publication and at research conferences. Ethical review is not required for this study.

Identifiants

pubmed: 34162633
pii: bmjopen-2020-043377
doi: 10.1136/bmjopen-2020-043377
pmc: PMC8231038
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e043377

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Eur Respir J. 2014 Dec;44(6):1428-46
pubmed: 25359355
Chest. 2006 Mar;129(3):536-44
pubmed: 16537849
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
BMJ. 2014 Jul 08;349:g4315
pubmed: 25004917
Eur Respir J. 2014 Dec;44(6):1447-78
pubmed: 25359356
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
J Clin Epidemiol. 2003 Dec;56(12):1170-6
pubmed: 14680667
Chest. 2007 Mar;131(3):696-704
pubmed: 17356082
Cochrane Database Syst Rev. 2016 Dec 08;12:CD005305
pubmed: 27930803
Lancet Respir Med. 2014 Mar;2(3):195-203
pubmed: 24621681
Eur Respir J. 2017 Mar 15;49(3):
pubmed: 28298398
COPD. 2005 Mar;2(1):81-9
pubmed: 17136967

Auteurs

Kai Zhu (K)

Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.

Jagdeep Gill (J)

Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.

Ashley Kirkham (A)

Centre for Heart Lung Innovation, The University of British Columbia, Vancouver, British Columbia, Canada.

Joel Chen (J)

Centre for Heart Lung Innovation, The University of British Columbia, Vancouver, British Columbia, Canada.
Respiratory Medicine, University of Calgary, Calgary, Alberta, Canada.

Amy Ellis (A)

Surrey Memorial Hospital, Fraser Health Authority, Surrey, British Columbia, Canada.

Stephanie Crosbie (S)

S. Crosbie Consulting, Vancouver, British Columbia, Canada.

Holly Denson-Camp (H)

Centre for Heart Lung Innovation, The University of British Columbia, Vancouver, British Columbia, Canada.

Hannah Peters (H)

Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.

Pat Camp (P)

Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada pat.camp@hli.ubc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH